Skip to Main Content

INFORMATION FOR

Barbara Gulanski, MD, MPH

Medical Services Provider; Co-Chair SWIM, Status of Women in Medicine Committee (SWIM); Associate Chief for Education, Endocrinology

Contact Information

Barbara Gulanski, MD, MPH

Patient Care Location

Mailing Address

  • Endocrinology

    PO Box 208020, 333 Cedar St

    New Haven, CT 06520-8020

    United States

Appointments

Biography

Most recently, Dr. Gulanski served as Site Investigator at VA Connecticut Healthcare System for the NIH funded GRADE Study (Glycemic Reduction Approaches in Diabetes: A Comparative Effectiveness Study), a multi-center nationwide randomized study to determine the best combination of glucose-lowering medications for management of type 2 diabetes mellitus. She is an investigator at the Clinical Epidemiology Research Center (CERC) at VA Connecticut Healthcare System, a sub-investigator on the “Randomized, Double-Blind, Placebo-controlled, Phase 2/3 Study to Assess the Efficacy and Safety of Setrusumab in Subjects with Osteogenesis Imperfecta” protocol and a co-investigator on a VA HSR&D study “Understanding Suicide Risks Among LGBT Veterans in VA Care”. 

Soon after joining the Yale faculty, she was a member of the grant writing team for the initial Clinical and Translational Science Award (CTSA) which was awarded to Yale in 2006 and which supports the Yale Center for Clinical Investigation (YCCI). She was a member of the National CTSA Participant and Clinical Interaction Steering Committee, NCRR/NIH, and served as Director of the Yale New Haven Hospital Research Unit (HRU) until 2009. From 2008-2016, she was the Associate Director, Diabetes Research Center (DRC) Translational Research Core. Her other administrative roles include, among others, Section Chief for Endocrinology at the VA Connecticut Healthcare System (2000-2005, 2009-2013), Chair, Section of Endocrinology Diversity Task Force (2019-2021), and she currently serves as Associate Chief for Education, Yale Section of Endocrinology.  She has been an active member of the Status of Women in Medicine (SWIM) Executive Committee since 2018. 

Her clinical interests include metabolic bone disease and transgender care. She is a clinician at the Yale Bone Center. At Yale Health, she helped to develop a multidisciplinary transgender medicine program to provide integrated care for individuals seeking gender affirming care.

After retiring from Yale in 2017, she returned and maintains a clinical practice at the Yale Bone Center and is active in clinical research studies and teaching at Yale and VA Connecticut.

Education & Training

  • MPH
    Yale School of Public Health (1999)
  • Resident
    Temple University Hospital (1985)
  • MD
    New York University (1982)

Departments & Organizations